CJMB · Callan Jmb Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q4 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.11M | - | $1.45M | $1.99M | $1.79M | - | - | - |
| Cost of Revenue | $678.9K | - | $970.9K | $1.02M | $1.07M | - | - | - |
| Gross Profit | $427.2K | - | $493.3K | $643.9K | $717.6K | - | - | - |
| R&D | - | - | - | - | - | - | - | - |
| SG&A | $2.13M | - | $1.25M | $1.10M | $805.0K | - | - | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - |
| D&A | $37.9K | - | $35.5K | $35.5K | $35.6K | - | - | - |
| Operating Income | ($1.70M) | - | ($1.88M) | ($133.4K) | ($87.5K) | - | - | - |
| Interest Expense | - | - | $458 | $1.8K | $3.1K | - | - | - |
| Income Tax | $306 | - | $26.0K | ($20.0K) | ($6.0K) | - | - | - |
| Net Income | ($3.22M) | - | ($805.0K) | ($1.40M) | ($81.1K) | - | - | - |
| EPS - Basic | ($0.32) | - | ($0.61) | ($0.04) | ($0.03) | - | - | - |
| EPS - Diluted | ($0.32) | - | ($0.61) | ($0.31) | ($0.03) | - | - | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q4 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.42M | $2.13M | $2.79M | $4.22M | $5.22M | $2.10M | $5.16M | - |
| Accounts Receivable | $823.6K | $343.2K | $945.8K | $614.2K | $835.0K | $622.9K | $2.90M | - |
| Inventory | $218.1K | $243.3K | $223.2K | $197.5K | $216.0K | $158.4K | $114.7K | - |
| Accounts Payable | $583.3K | $564.0K | $318.8K | $430.9K | $371.7K | - | - | - |
| Current Assets | $3.03M | $3.06M | $4.29M | $5.59M | $6.80M | $3.32M | $8.45M | - |
| Total Assets | $5.71M | $5.78M | $7.74M | $8.97M | $8.46M | $5.08M | $9.71M | - |
| Current Liabilities | $1.52M | $1.41M | $1.19M | $1.31M | $1.05M | $1.28M | $769.7K | - |
| Long-term Debt | - | - | - | - | - | - | - | - |
| Total Liabilities | $4.11M | $3.45M | $3.56M | $3.14M | $1.65M | $1.91M | $910.3K | - |
| Stockholders' Equity | $1.60M | $2.33M | $4.18M | $5.22M | $6.81M | $3.17M | $8.80M | $14.01M |
| Retained Earnings | ($13.48M) | ($10.26M) | ($7.67M) | ($4.94M) | ($3.53M) | ($2.29M) | - | - |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q4 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($1.68M) | - | - | - | $6.8K | - | - | - |
| Investing Cash Flow | ($35.3K) | - | - | - | ($44.7K) | - | - | - |
| Financing Cash Flow | $1.00M | - | - | - | ($3.46M) | - | - | - |
| CapEx | $35.3K | - | - | - | $44.7K | - | - | - |
| Free Cash Flow | ($1.72M) | - | - | - | ($37.8K) | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q4 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||
| Gross margin | 38.6% | - | 34.1% | 32.4% | 40.1% | - | - | - |
| Operating margin | -153.8% | - | -129.9% | -6.7% | -4.9% | - | - | - |
| EBITDA margin | -150.4% | - | -127.4% | -4.9% | -2.9% | - | - | - |
| Net margin | -290.7% | - | -55.6% | -70.4% | -4.5% | - | - | - |
| Free cash flow margin | -155.1% | - | - | - | -2.1% | - | - | - |
| FCF / Net income | 0.53 | - | - | - | 0.47 | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 192.4% | - | 86.1% | 55.2% | 45.0% | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - |
| Return on assets | -56.3% | - | -10.4% | -15.6% | -1.0% | - | - | - |
| Return on equity | -201.0% | - | -19.3% | -26.8% | -1.2% | - | - | - |
| Return on invested capital | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||
| Current ratio | 2.00 | 2.16 | 3.60 | 4.26 | 6.49 | 2.59 | 10.98 | - |
| Quick ratio | 1.86 | 1.99 | 3.42 | 4.11 | 6.28 | 2.47 | 10.83 | - |
| Cash ratio | 0.93 | 1.51 | 2.34 | 3.22 | 4.98 | 1.64 | 6.70 | - |
| Leverage | ||||||||
| Debt / Equity | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | -4103.0x | -73.9x | -28.1x | - | - | - |
| Equity multiplier | 3.57 | 2.48 | 1.85 | 1.72 | 1.24 | 1.60 | 1.10 | - |
| Liabilities / Assets | 0.72 | 0.60 | 0.46 | 0.35 | 0.19 | 0.38 | 0.09 | - |
| Efficiency | ||||||||
| Asset turnover | 0.19 | - | 0.19 | 0.22 | 0.21 | - | - | - |
| Inventory turnover | 3.11 | - | 4.35 | 5.18 | 4.97 | - | - | - |
| Days sales outstanding | 272d | - | 239d | 113d | 170d | - | - | - |
| Days inventory outstanding | 117d | - | 84d | 70d | 73d | - | - | - |
| Days payable outstanding | 314d | - | 120d | 154d | 126d | - | - | - |
| Cash conversion cycle | 75d | - | 203d | 30d | 117d | - | - | - |
| Valuation | ||||||||
| P / E | - | - | - | - | - | - | - | - |
| P / B | 3.0x | - | 3.5x | 2.9x | 1.6x | - | - | - |
| P / S | 4.4x | - | 10.1x | 7.7x | 6.3x | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| Growth | ||||||||
| Revenue growth (YoY) | -38.2% | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | -40.5% | - | - | - | - | - | - | - |
| Operating income growth (YoY) | -1845.1% | - | - | - | - | - | - | - |
| Net income growth (YoY) | -3862.7% | - | - | - | - | - | - | - |
| EPS growth (YoY) | -966.7% | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | -4435.5% | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -76.5% | -26.6% | - | - | - | -63.9% | -37.2% | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Product / service
$5.74M totalEmergency Preparedness$3.98M · 69.3%
Specialty Packaging$1.74M · 30.4%
Service$16.8K · 0.3%
Peer comparison
Same SIC group: Services-Business Services, NEC
Comparing CALLAN JMB INC. against the 5 most active filers in the same SIC group.